Journal of the American Chemical Society
Page 8 of 10
1
2
3
4
5
6
7
Immunostaining. Primary cells and islets were fixed in 4%
with editing the manuscript. The author also thanks to Ms
Paraformaldehyde and permeabilized with 0.1% Triton-X 100.
Fixed Cells were identified by primary antibodies for over-
night at 4° C at the respective dilutions. For alpha cell - Glu-
cagon antibody (Monoclonal Anti-Glucagon antibody pro-
duced in mouse, G2654, Sigma-Aldrich 3050 Spruce St. St.
Louis, USA) 1:2000. Another mice pancreatic alpha cell
Tong Yan and Keshmarathy D/O Sacadevan of NUS Centre
of Bio-Imaging Science; for Two-Photon imaging facility.
This study was supported by intramural funding from
A*STAR (Agency for Science, Technology and Research, Sin-
gapore) Biomedical Research Council, and Oasis Grant from
KRICT, South Korea.
8
9
marker GABAA receptor antibody (Anti-GABA A Receptor β
REFERENCES
2,3 Chain Antibody, clone BD17 produced in mouse: MAB341,
Merck Millipore,) 1:200. For Insulin (Insulin [L6B10] Mouse
mAb, Cell Signaling #8138) 1:200. For secondary antibody
staining, Cy5® goat anti-mouse IgG (Invitrogen, Molecular
Probes Inc, USA) was used for all three primary antibodies.
Flow-cytometry analysis was done by BD LSR II Flow Cytom-
eter.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(1)
Quesada, I.; Tuduri, E.; Ripoll, C.; Nadal, A.J. En-
docrino. 2008, 199, 5.
(2)
Cabrera, O.; Berman, D. M.; Kenyon, N. S.; Ricordi,
C.; Berggren, P. O.; Caicedo, A. Pro. Natl. Acad. Sci. U. S. A.
2006, 103, 2334.
(3)
Kang, N. Y.; Lee, S. C.; Park, S. J.; Ha, H. H.; Yun, S.
W.; Kostromina, E.; Gustavsson, N.; Ali, Y.; Chandran, Y.;
Chun, H. S.; Bae, M.; Ahn, J. H.; Han, W.; Radda, G. K.; Chang,
Y. T. Angew. Chem. Int. Ed. Engl.2013, 52, 8557.
Cytotoxicity assays. Cytotoxicity assays were carried out
using the MTS reagent kit (Promega) for 1-24 h, with 1 and 2
μM TP-α treated alpha and beta cells in accordance with the
manufacturer's instructions.
(4)
Latif, Z. A.; Noel, J.; Alejandro, R. Transplantation
1988, 45, 827.
Flow cytometry. Primary islet cell cultures were generated
from the islets of C57BL/6 (WT) male mice as described
above. Cells were stained with 1 μM of TP-α for 1 h at 37° C
and washed with Phosphate Buffer Saline (PBS) before acqui-
sition on the BD LSR II analyzer. Cells were acquired using
the appropriate filters for TP-α (DAPI; excitation laser light
355 nm and emission at 450/50 nm, Long pass filter 410 nm),
and secondary antibody Cy5; excitation laser light 640 nm
and emission at 660/20 nm.
(5)
Lukowiak, B.; Vandewalle, B.; Riachy, R.; Kerr-Conte,
J.; Gmyr, V.; Belaich, S.; Lefebvre, J.; Pattou, F. J. Histochem.
Cytochem. 2001, 49, 519.
(6)
Henquin, J. C.; Gilon, P. FEBS let. 2007, 581, 4235.
(7) Bennett, B. D.; Jetton, T. L.; Ying, G.; Magnuson, M.
A.; Piston, D. W. J. Biol. Chem. 1996, 271, 3647.
(8) Asada, N.; Shibuya, I.; Iwanaga, T.; Niwa, K.; Kanno,
T. Diabetes 1998, 47, 751.
Quoix, N.; Cheng-Xue, R.; Guiot, Y.; Herrera, P. L.;
(9)
Lee, J. S.; Kang, N. Y.; Kim, Y. K.; Samanta, A.; Feng,
ASSOCIATED CONTENT
Supporting Information
S.; Kim, H. K.; Vendrell, M.; Park, J. H.; Chang, Y. T. J. Am.
Chem. Soc. 2009, 131, 10077.
(10) Helmchen, F.; Denk, W. Nat. Methods2005, 2, 932.
Detailed synthetic procedure and building block structures
with characterization are available in Supporting Infor-
mation. “This material is available free of charge via the In-
(11)
Takahashi, N.; Nemoto, T.; Kimura, R.; Tachikawa,
A.; Miwa, A.; Okado, H.; Miyashita, Y.; Iino, M.; Kadowaki, T.;
Kasai, H. Diabetes 2002, 51 Suppl 1, S25.
(12) Lee, S. J.; Rao, A. S.; Shin, Y. H.; Chung, H. J.; Huh, Y.;
Ahn, K. H.; Jung, J. J. Mol. Histol. 2013, 44, 241.
AUTHOR INFORMATION
Corresponding Authors
(13)
Kang, N. Y.; Ha, H. H.; Yun, S. W.; Yu, Y. H.; Chang, Y.
T. Chem. Soc. Rev. 2011, 40, 3613.
(14) Yun, S. W.; Kang, N. Y.; Park, S. J.; Ha, H. H.; Kim, Y.
K.; Lee, J. S.; Chang, Y. T. Acc. Chem. Res. 2014, 47, 1277.
(15) Ljosa, V.; Carpenter, A. E. Trends Biotechnol. 2008,
26, 527.
(16) Yoo, J. S.; Lee, S. C.; Jow, Z. Y.; Koh, P. Y.; Chang, Y. T.
Cancer Res. 2014, 74, 44.
(17) Leong, C.; Zhai, D.; Kim, B.; Yun, S. W.; Chang, Y. T.
Stem cell Res. 2013, 11, 1314.
(18) Lee, J. S.; Kim, Y. K.; Kim, H. J.; Hajar, S.; Tan, Y. L.;
Kang, N. Y.; Ng, S. H.; Yoon, C. N.; Chang, Y. T.PLoS One.
2012,7, e32096.
(19) Speier, S.; Nyqvist, D.; Cabrera, O.; Yu, J.; Molano, R.
D.; Pileggi, A.; Moede, T.; Kohler, M.; Wilbertz, J.; Leibiger, B.;
Ricordi, C.; Leibiger, I. B.; Caicedo, A.; Berggren, P. O. Nat.
Med. 2008, 14, 574.
(20) Steiner, D. J.; Kim, A.; Miller, K.; Hara, M. Islets 2010,
2, 135.
Nam-Young Kang, PhD. Laboratory of Bioimaging Probe
Development, Singapore Bioimaging Consortium, Agency for
Science, Technology and Research, Singapore 138667, Repub-
lic of Singapore. Telephone: +65-6478-8760; Fax: +65-6478-
9957;
e-mail: kang_nam_young@sbic.a-star.edu.sg
Professor Young-Tae Chang, S9-03-01, 3-Science Drive 2, De-
partment of Chemistry, National University of Singapore,
Singapore 117543; Tel: (+65) 6478 8736; Fax: (+65) 6478 9957
e-mail: chmcyt@nus.edu.sg
Notes
The authors declare no competing financial interests.
ACKNOWLEDGMENT
(21) Lernmark, A. Diabetologia 1974, 10, 431.
(22) Bailey, S. J.; Ravier, M. A.; Rutter, G. A. Diabetes 2007,
The authors thank Dr. A. Samanta, Dr. R. K. Das, Dr. K. K.
Ghos, Dr. C. L. Teoh and Dr. S. Balasubramaniam for help
8
ACS Paragon Plus Environment